TI
AGIO icon

Tidal Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Tidal Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
16,100
+1,724
+12% +$52.3K ﹤0.01% 2009
2026
Q1 		$486K Buy
14,376
+129
+0.9% +$3.66K ﹤0.01% 1844
2025
Q4 		$388K Sell
14,247
-667
-4% -$23.4K ﹤0.01% 1763
2025
Q3 		$599K Sell
14,914
-646
-4% -$24.3K ﹤0.01% 1470
2025
Q2 		$518K Sell
15,560
-3,658
-19% -$111K ﹤0.01% 1379
2025
Q1 		$563K Sell
19,218
-1,571
-8% -$52.1K ﹤0.01% 1261
2024
Q4 		$683K Sell
20,789
-1,038
-5% -$48.8K 0.01% 1210
2024
Q3 		$970K Sell
21,827
-742
-3% -$33.7K 0.01% 1000
2024
Q2 		$973K Sell
22,569
-9,767
-30% -$352K 0.01% 914
2024
Q1 		$946K Buy
+32,336
New +$866K 0.02% 904

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Tidal Investments's AGIO Position: Q2 2026 in Review

Tidal Investments increased its Agios Pharmaceuticals (AGIO) stake by 12% in Q2 2026, buying an estimated $52.3K and bringing the position to 16,100 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

Tidal Investments first reported a position in AGIO in Q1 2024 and has held it in 10 quarters since. The position peaked at $973K in Q2 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Tidal Investments held 16,100 shares of Agios Pharmaceuticals worth $597K as of Q2 2026.
  • Tidal Investments bought 1,724 Agios Pharmaceuticals shares in Q2 2026, an estimated $52.3K.
  • Agios Pharmaceuticals made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2009 holding.
  • Tidal Investments first reported a position in Agios Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Tidal Investments's Agios Pharmaceuticals position peaked at $973K in Q2 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.